Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Millennium Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00807495
First received: December 11, 2008
Last updated: November 15, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 19, 2012